前列腺癌ADT患者体成分与疲劳及运动的关系
研究229例接受ADT的前列腺癌患者,横断面分析显示疲劳者总脂肪量和躯干脂肪量更高,但瘦体重与疲劳无关。129例患者接受3-6个月监督运动后,疲劳和活力改善与瘦体重变化相关,与脂肪量无关。
要点
- ADT治疗中前列腺癌患者,疲劳者总脂肪量和躯干脂肪量显著高于非疲劳者。
- 瘦体重与横断面疲劳无关,但运动后瘦体重增加与疲劳改善相关。
- 运动医学应关注改善体成分(瘦体重和脂肪量)以减轻癌因性疲劳。
核心结论
- 在接受ADT的前列腺癌患者中,体成分与疲劳相关,临床相关疲劳者总脂肪量和躯干脂肪量更高。
- 运动后不再疲劳者伴随瘦体重大幅增加,改善体成分可能有利改变癌因性疲劳水平。
研究设计与样本
- 横断面分析纳入229例接受ADT的前列腺癌患者,年龄43-90岁。
- 前瞻性分析纳入129例接受3-6个月监督运动计划(以抗阻+有氧为主)的患者。
- 采用双能X线吸收法评估全身和四肢瘦体重、总脂肪量和躯干脂肪量。
- 疲劳采用EORTC QLQ-30评估,活力采用SF-36评估。
主要发现
- 基于EORTC QLQ-30,19%的患者有临床相关疲劳。
- 疲劳者总脂肪量(P=0.013)、躯干脂肪量(P=0.015)和脂肪百分比(P=0.008)均高于非疲劳者,总脂肪量和躯干脂肪量分别高5.0 kg和2.6 kg。
- 活力最低四分位组脂肪量最高(P=0.014-0.034)。
- 运动后疲劳变化与总瘦体重变化相关(r=-0.182,P=0.042),活力变化与总瘦体重变化相关(r=0.309,P=0.001),但与脂肪量变化无关。
- 基线疲劳而运动后不疲劳者瘦体重中位数增加2.1 kg(四分位距0.7-3.2 kg)。
临床怎么用
- 对接受ADT的前列腺癌患者,应评估体成分(瘦体重和脂肪量)以识别疲劳风险。
- 监督运动计划(抗阻+有氧)可能通过增加瘦体重改善疲劳和活力。
- 运动医学干预应针对改善体成分,作为管理癌因性疲劳的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the association between lean mass (LM) and fat mass (FM) with fatigue and vitality before and after exercise in patients with prostate cancer already undergoing androgen-deprivation therapy (ADT). SUBJECTS AND METHODS: Cross-sectional associations between LM and FM with fatigue and/or vitality measures were examined in 229 patients (aged 43-90 years). Prospective analysis was undertaken in 129 patients who underwent a supervised 3-6 months exercise programme (predominantly resistance + aerobic). Whole body and appendicular LM, and total and trunk FM were assessed by dual X-ray absorptiometry. Fatigue was assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-30) and vitality using the Short Form-36. RESULTS: Based on the EORTC QLQ-30, 19% of patients had clinically relevant fatigue. There was no association between LM and fatigue; however, total (P = 0.013), trunk (P = 0.015) and percentage (P = 0.008) FM were higher in fatigued than not fatigued patients, with total and trunk FM 5.0 and 2.6 kg higher, respectively. For quartiles of vitality, a similar pattern emerged for FM with those in the lowest quartile of vitality having the highest FM values (P = 0.014-0.034). In contrast, following supervised exercise, change in fatigue and vitality were associated with change in total LM (r = -0.182, P = 0.042 and r = 0.309, P = 0.001, respectively) but not FM. Patients fatigued at baseline but not fatigued following the exercise programme gained a median (interquartile range) of 2.1 (0.7-3.2) kg LM. CONCLUSION: In patients with prostate cancer treated with ADT, body composition is associated with fatigue, with higher total and trunk FM in those with clinically relevant fatigue. However, following exercise those no longer fatigued had an accompanying substantial increase in LM. Modifying body composition, both LM and FM, in patients with prostate cancer may favourably alter cancer-related fatigue levels and should be a target of exercise medicine in this population.
引用
- Newton RU, Jeffery E, Galvão DA, et al. Body composition, fatigue and exercise in patients with prostate cancer undergoing androgen-deprivation therapy. BJU Int. 2018. PMID: 29750398. doi:10.1111/bju.14384
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。